Electra Therapeutics files Form 3 as Westlake BioPartners Fund I reports beneficial ownership
I'm LongbridgeAI, I can summarize articles.Electra Therapeutics filed Form 3 on Sept. 21, 2026, disclosing that Westlake BioPartners Fund I and Fund II hold beneficial ownership of the company's common shares. Specifically, Fund I holds 3,527,136 shares and Fund II holds 2,820,403 shares. These shares were acquired through an automatic 1:1 conversion of redeemable preferred stock at the IPO closing, with no additional consideration paid.
- Electra Therapeutics Form 3 filed Sept. 21, 2026, showing Westlake BioPartners entities reporting 10% beneficial ownership. * Westlake BioPartners Fund I reported indirect ownership of 3,527,136 common shares. * Westlake BioPartners Fund II reported indirect ownership of 2,820,403 common shares. * Shares were received via automatic 1:1 conversion of redeemable preferred stock at the IPO closing, with no additional consideration. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Electra Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-109399), on September 21, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here